相关实验视频
Updated: Jul 13, 2026

Isolation and Activation of Murine Lymphocytes
Published on: October 30, 2016
在B淋巴细胞分化过程中,MTA3和Mi-2/NuRD复合体调节细胞命运
Naoyuki Fujita1, David L Jaye, Cissy Geigerman
1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
MTA3是BCL-6转录抑制剂的新型辅因子,对B淋巴细胞命运至关重要. 减少MTA3会影响BCL-6的功能,改变B细胞的发育和血细胞的分化.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 转录抑制剂BCL-6在生殖中心反应期间控制B淋巴细胞的细胞命运.
- BCL-6 防止B淋巴细胞过早分化为血细胞.
研究的目的:
- 为了确定参与BCL-6依赖细胞命运决定的辅因子.
- 阐明MTA3在BCL-6介导的转录抑制中的作用.
主要方法:
- 对于MTA3枯竭的RNA干扰 (RNAi).
- 同免疫沉以评估BCL-6/Mi-2/NuRD相互作用.
- 对B淋巴细胞和血细胞的转录模式和细胞表面标记物的分析.
主要成果:
- 作为Mi-2/NuRD复合体的一个子单元,MTA3与BCL-6相互作用.
- 在生殖中心,MTA3与BCL-6共同表达.
- MTA3的枯竭会影响BCL-6的抑制,并改变B细胞特异性基因表达.
- 血细胞中的BCL-6表达,依赖于MTA3,抑制血细胞基因并重新激活B细胞程序.
结论:
- 在调节B淋巴细胞细胞命运方面,MTA3是BCL-6的关键辅因子.
- MTA3促进BCL-6介导的抑制,影响B细胞增殖和血细胞分化之间的平衡.
- 针对BCL-6/MTA3相互作用可能为B细胞恶性瘤提供治疗策略.
更多相关视频
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
08:25Flow Cytometric Characterization of Murine B Cell Development
Published on: January 22, 2021
相关概念视频
Microtubule Formation
Assembly of Complex Microtubule Structures
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...